Related Experiment Video

Updated: Oct 5, 2026

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

[Perinatal morbidity and mortality in children born to mothers with gestational hypertension]

B Galanti1, C T Kaihura, L Ricci

  • 1Cattedra di Ginecologia e Ostetricia, Clinica Ostetrica e Ginecologica, Università degli Studi di Parma.

Acta Bio-Medica De L'Ateneo Parmense : Organo Della Societa Di Medicina E Scienze Naturali Di Parma
|June 27, 2001
PubMed

Insights

Gestational hypertension significantly increases risks for mothers and newborns, leading to premature birth, low birth weight, and higher still-birth rates. Key risk factors include advanced maternal age, nulliparity, and obesity.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Epidemiology

Context:

  • Gestational hypertension is a serious pregnancy complication with significant maternal and neonatal implications.
  • It is a leading cause of maternal morbidity and contributes to perinatal mortality through fetal hypoxia, prematurity, and low birth weight.
  • Current management primarily involves delivery, with timing and method dictated by hypertension severity and maternal/fetal complications.

Purpose:

  • To investigate the clinical course and identify risk factors for gestational hypertension.
  • To compare maternal and neonatal outcomes between women with gestational hypertension and a healthy control group.

Summary:

  • A clinical-epidemiological study analyzed 50 women with gestational hypertension and 80 controls.
  • Identified risk factors for gestational hypertension include advanced maternal age, nulliparity, and elevated BMI.
  • Hypertensive pregnancies resulted in higher rates of premature birth, cesarean sections, lower birth weights (newborn and placenta), reduced Apgar scores, increased NICU admissions, and a 14% still-birth rate.

Impact:

  • Findings highlight the severe adverse effects of gestational hypertension on neonatal outcomes, including prematurity and mortality.
  • Identifies key maternal risk factors, aiding in early risk assessment and potential intervention strategies.
  • Emphasizes the critical need for vigilant monitoring and management of gestational hypertension to improve maternal and neonatal prognosis.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...